Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Mar 28;57(4):e01417-18.
doi: 10.1128/JCM.01417-18. Print 2019 Apr.

Improved Performance of a Rapid Immunochromatographic Assay for Detection of PBP2a in Non-Staphylococcus aureus Staphylococcal Species

Affiliations

Improved Performance of a Rapid Immunochromatographic Assay for Detection of PBP2a in Non-Staphylococcus aureus Staphylococcal Species

Matthew C Canver et al. J Clin Microbiol. .

Abstract

Non-Staphylococcus aureus staphylococcal species (non-SASS) are important pathogens in both animal and human populations. The development of β-lactam resistance in non-SASS through acquisition and expression of penicillin-binding protein 2a (PBP2a) represents a significant clinical and public health threat. Here, we evaluated the diagnostic performance of two versions of a PBP2a immunochromatographic assay with non-SASS. Our data show that the revised version of the assay, the PBP2a SA culture colony test, has superior diagnostic sensitivity compared to the previous version of the assay, the PBP2a culture colony test, 100% (95% confidence interval [CI], 93.3 to 100%) versus 67.9% (95% CI, 53.7 to 80.1%), respectively, while both assays display a specificity of 100% (95% CI, 92.5 to 100%). Therefore, the PBP2a SA culture colony test offers a rapid, accurate, and relatively inexpensive method for detecting PBP2a-mediated β-lactam resistance in clinically relevant non-SASS for the management of infections due to these organisms and for antimicrobial stewardship.

Keywords: PBP2a; Staphylococcus; beta-lactam resistance; methicillin resistance.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Becker K, Heilmann C, Peters G. 2014. Coagulase-negative staphylococci. Clin Microbiol Rev 27:870–926. doi:10.1128/CMR.00109-13. - DOI - PMC - PubMed
    1. Frank KL, Del Pozo JL, Patel R. 2008. From clinical microbiology to infection pathogenesis: How daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 21:111–133. doi:10.1128/CMR.00036-07. - DOI - PMC - PubMed
    1. Argemi X, Hansmann Y, Riegel P, Prévost G. 2017. Is Staphylococcus lugdunensis significant in clinical samples? J Clin Microbiol 55:3167–3174. doi:10.1128/JCM.00846-17. - DOI - PMC - PubMed
    1. Fitzgerald JR. 2009. The Staphylococcus intermedius group of bacterial pathogens: species re-classification, pathogenesis and the emergence of meticillin resistance. Vet Dermatol 20:490–495. doi:10.1111/j.1365-3164.2009.00828.x. - DOI - PubMed
    1. Peacock SJ, Paterson GK. 2015. Mechanisms of methicillin resistance in Staphylococcus aureus. Annu Rev Biochem 84:577–601. doi:10.1146/annurev-biochem-060614-034516. - DOI - PubMed

Publication types

Substances

LinkOut - more resources